JENNIFER ROSSI: Open Payments
NPI 1184208449 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 21 payments from 7 companies in 2025. Trend: 2023 $1,115 · 2024 $630 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $144 |
| Lundbeck LLC | 4 | $103 |
| Janssen Pharmaceuticals, Inc | 4 | $60 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $17 |
Products named: CAPLYTA, REXULTI, INVEGA SUSTENNA, FANAPT, Auvelity, VRAYLAR.
Industry payments across MS — which companies pay providers there.
